Lv0
0 积分 2023-06-18 加入
Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial
2天前
已完结
MEF2D-expressing cancer precursors reprogram tissue-resident macrophages to support liver tumorigenesis
29天前
已完结
Neoadjuvant immunotherapy in mismatch-repair-proficient colon cancers
1个月前
已完结
Where Is the Future of Adjuvant Therapy for Hepatocellular Carcinoma?
1个月前
已完结
Distinct Single-cell Immune Ecosystems Distinguish True and De Novo HBV-related Hepatocellular Carcinoma Recurrences
1个月前
已完结
FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2个月前
已完结
Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling
4个月前
已完结
Targeting the GLP-1/GLP-1R axis to treat osteoarthritis: A new opportunity?
4个月前
已完结
The Enzymes, Regulation, and Genetics of Bile Acid Synthesis
4个月前
已完结
Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments
4个月前
已完结
皖公网安备34019202002308
